We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
QIAGEN and Applied Biosystems Settle all Disputes over Real-Time PCR Thermal Cycler Patents
News

QIAGEN and Applied Biosystems Settle all Disputes over Real-Time PCR Thermal Cycler Patents

QIAGEN and Applied Biosystems Settle all Disputes over Real-Time PCR Thermal Cycler Patents
News

QIAGEN and Applied Biosystems Settle all Disputes over Real-Time PCR Thermal Cycler Patents

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "QIAGEN and Applied Biosystems Settle all Disputes over Real-Time PCR Thermal Cycler Patents"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

QIAGEN and Applied Biosystems have announced a settlement of their disputes concerning infringement by Corbett’s Rotor-Gene™ Real-Time PCR-Cyclers and Applied Biosystems’ Real-Time Thermal Cycler Instrument patents.

Applied Biosystems had filed an infringement lawsuit against Corbett in Germany and Corbett later filed a declaratory judgment lawsuit in California. Further, Corbett and ltf Labortechnik filed an intervention in opposition proceedings before the European Patent Office. QIAGEN acquired Corbett, an Australian instrumentation manufacturing company, in July 2008.

In connection with the settlement, Corbett has entered into an agreement with Applied Biosystems to take a license to certain technology relating to Corbett’s Real-Time PCR-Instrumentation and its use. The license covers all fields including research-related fields, applied fields and the fields of human and animal in vitro diagnostics.

Financial terms of the settlement and related license agreement were not disclosed. These agreements fully resolve all pending disputes between Corbett, QIAGEN, ltf Labortechnik, and Applied Biosystems.
Advertisement